Huntington’s Disease Clinical Trials
Enroll-HD
CLINICAL TRIALS CURRENTLY RECRUITING
Department of Neurology
Department of Neurology
Enroll-HD
Study Title: A Prospective Registry Study in a Global Huntington’s Disease Cohort (A CHDI Foundation Project)
Purpose: To collect clinical information about subjects and their health. In addition, biological samples (DNA and blood) will be collected to learn more about HD and try to find new treatments for the disease.
Study drug: No study medication or device
Duration of study: No study medication or device
Inclusion criteria:
- Age 18 or older
- Carriers: individuals with the HD gene expansion mutation
- Genotype Unknown: first or second degree relatives who have not undergone HD testing, and have an unknown carrier type
- Family/Community Controls: individuals without HD or any family history of HD
Exclusion criteria:
- Have choreic movement disorders in the context of a negative test for the HD mutation
- For controls: history of concurrent major central nervous system (e.g., stroke, Parkinson’s disease, etc.)
Please note: the above may not be a complete list of inclusion and/or exclusion criteria
For more information, please contact the UC Irvine Neurology Clinical Trials Unit at one of the following:
Rene Anguiano
Clinical Research Coordinator
UCI Center for Clinical Research
Office: (714) 790-8532 | Fax: (949) 824-8352
renea1@hs.uci.edu
Rene Anguiano
Clinical Research Coordinator
UCI Center for Clinical Research
Office: (714) 790-8532 | Fax: (949) 824-8352
renea1@hs.uci.edu
Huntington Study Group
Find out information on possible studies via the HD Drug Pipeline. Click here for more information.
To find other HD trials that may be available, please visit HDTrialFinder